Skip to main content
Showing 35,658 results
Pharmaceutical industry
Are 2 million bottles of PrEP an empty gesture?
Editor's pick
The Lancet HIV
15 July 2019
HIV prevention policy
How Australia Could Almost Eradicate H.I.V. Transmissions
Editor's pick
15 July 2019
The search for an HIV prevention vaccine
J&J’s Quest for Elusive HIV Vaccine Is Poised for Major Test
Editor's pick
Bloomberg
15 July 2019
People & personal stories
Professor Chloe Orkin: Chair of the British HIV Association
Editor's pick
Audioboom / The Dorothy Project
15 July 2019
Chemsex & recreational drug use
Gay and bisexual men with problematic chemsex are a diverse group with significant sexual and psycho-social risks
News
15 July 2019
PrEP science
Trial Pairs PrEP With Behavioral Intervention to Prevent HIV in Drug Users
Editor's pick
Contagionlive.com
12 July 2019
PrEP programmes & uptake
How Australia Could Almost Eradicate H.I.V. Transmissions
Editor's pick
New York Times
12 July 2019
The search for an HIV prevention vaccine
Scripps Research-led consortium receives $129 million NIH award to bring new HIV vaccination approach into clinical testing
Editor's pick
Scripps Institute
12 July 2019
Global health initiatives
Meet the UNAIDS leadership contenders
Editor's pick
Devex
11 July 2019
Migrants, refugees & displaced people
UK: Foreigner's health issues insufficient to halt deportation
Editor's pick
Legalbrief
11 July 2019
PrEP policies & guidelines
In New York City, PrEP on Demand Is Now on the Menu for Men Who Have Sex With Men
Editor's pick
The Body Pro
11 July 2019
PrEP policies & guidelines
Insurance Will Soon Cover HIV Prevention, But Many People Who Need it Still Won't Have Access
Editor's pick
Vice
11 July 2019
Injectable & long-acting HIV treatment
ViiV Healthcare announces start of first-ever study to identify and evaluate approaches to implementing its once-monthly injectable HIV treatment in clinical practice
Editor's pick
ViiV Healthcare press release
11 July 2019
Kidney problems
Analysis Backs New Tenofovir’s Kidney Safety Over Old Version
Editor's pick
POZ
11 July 2019
Pharmaceutical industry
GSK touts new Dovato switching data. Is it enough to shake Gilead's HIV lead?
Editor's pick
FiercePharma
11 July 2019
Harm reduction
UK: Take home naloxone is not reaching those who most need it
Editor's pick
The BMJ
11 July 2019
HIV & criminal law
"Tiger Mandingo,” Who Got 30 Years For Not Telling Sex Partners He Had HIV, Is Free 25 Years Early
Editor's pick
BuzzFeed
11 July 2019
PrEP programmes & uptake
Australian gay and bisexual men interested in switching to on-demand PrEP
News
11 July 2019
Injectable & long-acting HIV treatment
Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics
Editor's pick
Lyndra Therapeutics press release
10 July 2019
Starting treatment
Starting ART at a high CD4 cell count has clear benefits for people with a low viral load
News
10 July 2019
Epidemiology
Louisiana HIV Rates Are the Lowest in a Decade
Editor's pick
POZ
10 July 2019
PrEP programmes & uptake
PrEP Trials Offer Insight for Reaching at-Risk Women in Sub-Saharan Africa
Editor's pick
Contagion Live
10 July 2019
PrEP programmes & uptake
Same-day PrEP initiation a favorable option for patients at risk for HIV
Editor's pick
Healio
10 July 2019
Vaccinations & immunisations
HPV vaccine for boys 'will prevent thousands of cancers'
Editor's pick
BBC News
9 July 2019
Pagination
First page
« First
Previous page
‹ Previous
…
Page
346
Page
347
Page
348
Page
349
Current page
350
Page
351
Page
352
Page
353
Page
354
…
Next page
Next ›
Last page
Last »